Co Diagnostics Inc (CODX) Actualités

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan PR...

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test PR Newswire SALT LAKE CITY...

Form 8-K - Current report

Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. PR Newswire SALT LAKE...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results PR Newswire SALT LAKE CITY, August 8, 2024...

Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago

Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR...

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE...

Form DEF 14A - Other definitive proxy statements

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR...

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 PR Newswire SALT LAKE CITY, June...

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform PR Newswire SALT LAKE...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities